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• We  studied  the  differential  effects  of  repetitive  magnetic  stimulation.
• We  used  low  and  high-frequency  repetitive  magnetic  stimulation.
• We  examined  neurotrophic/growth  factors  and  proliferation  in  neuroblasts.
• High-frequency  rMS  induced  upregulation  of  neurotrophic/growth  factors.
• Upregulation  of  neurotrophic/growth  factors  caused  cell  proliferation.
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a  b  s  t  r  a  c  t
Repetitive  magnetic  stimulation  is  a neuropsychiatric  and  neurorehabilitation  tool  that  can  be  used  to
investigate  the  neurobiology  of  sensory  and motor  functions.  Few  studies  have  examined  the effects  of
repetitive  magnetic  stimulation  on the modulation  of  neurotrophic/growth  factors  and  neuronal  cells
in vitro.  Therefore,  the  current  study  examined  the  differential  effects  of  repetitive  magnetic  stimula-
tion  on neuronal  cell  proliferation  as  well  as various  growth  factor  expression.  Immortalized  mouse
neuroblastoma  cells  were  used  as the  cell model  in  this  study.  Dishes  of  cultured  cells  were  randomly
divided  into  control,  sham,  low-frequency  (0.5 Hz,  1 Tesla)  and high-frequency  (10 Hz, 1  Tesla)  groups
(n  =  4 dishes/group)  and  were  stimulated  for  3 days. Expression  of  neurotrophic/growth  factors,  Akt and
Erk  was  investigated  by  Western  blotting  analysis  3 days  after  repetitive  magnetic  stimulation.  Neu-
roblastoma  cell  proliferation  was determined  with  a  cell  counting  assay.  There  were differences  in  cell
proliferation  based  on stimulus  frequency.  Low-frequency  stimulation  did not alter  proliferation  rela-
tive  to  the  control,  while  high-frequency  stimulation  elevated  proliferation  relative  to  the  control  group.
The expression  levels  of  brain-derived  neurotrophic  factor  (BDNF),  glial  cell line-derived  neurotrophic
factor  (GDNF),  neurotrophin-3  (NT-3)  and  platelet-derived  growth  factor  (PDGF)  were  elevated  in  the
high-frequency  magnetic  stimulation  group.  Akt and  Erk  expression  was  also  signiﬁcantly  elevated  in
the high-frequency  stimulation  group,  while  low-frequency  stimulation  decreased  the  expression  of  Akt
and Erk  compared  to the  control.  In conclusion,  we  determined  that  different  frequency  magnetic  stim-
ulation  had  an  inﬂuence  on  neuronal  cell  proliferation  via regulation  of Akt  and  ERK signaling  pathways
and  the  expression  of growth  factors  such  as  BDNF,  GDNF,  NT-3  and  PDGF.  These  ﬁndings  represent  a
promising  opportunity  to gain  insight  into  how  different  frequencies  of  repetitive  magnetic  stimulation
may  mediate  cell  proliferation.
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1. Introduction
Transcranial magnetic stimulation is based on electromagnetic
induction, which was initially observed by Michael Faraday almost
200 years ago [1]. A transcranial magnetic stimulator with a coil can
produce a short 100 ms  biphasic electromagnetic pulse, which gen-
erates an electric current in the central nervous system (CNS) [2].
The resulting magnetic ﬁeld induces electrical current in nervous
tissue and, at sufﬁcient strength, produces neuronal depolariza-
tion [3]. When administered at regular frequencies, this process
is referred to as ‘repetitive transcranial magnetic stimulation’ or
‘rTMS’ [4]. rTMS has been used to treat CNS diseases because it
non-invasively stimulates brain areas, and also has less pain and
fewer side-effects than other treatments [3,5]. rTMS is a neuropsy-
chiatric and neurorehabilitation tool [4,6,7] that can be used to
investigate the neurobiology of sensory and motor functions [6,8,9].
High-frequency (>3 Hz) stimulation generally results in facilitation,
while low-frequency (<1 Hz) rTMS induces reduction of synaptic
efﬁciency [10]. Based on this mechanism, several clinical trials have
revealed that rTMS provides kinetic function improvements and
change neurotransmitter system [6,7,11,12]. Additionally, other
studies have reported that rTMS affects neural stem cell prolifer-
ation in the subventricular zone [13]. However, few studies have
examined the in vitro and in vivo effects of repetitive magnetic
stimulation. The effects of stimulation in different frequencies also
remain uncertain. Therefore, we examined changes in cell prolif-
eration and expression of growth factors in mouse neuroblastoma
cells.
2. Materials and methods
2.1. Cell cultures
The immortalized mouse neuroblastoma cell line N1E-115
(ATCC® CRL-2263TM), which expresses normal neuronal phe-
notypes, was used as a cell model in this study. Mouse
neuroblastoma cells were seeded at 2 × 105 cells/cm2 in 100
culture dish in Dulbecco’s Modiﬁed Eagle Medium without
pyruvate (DMEM; Invitrogen-Gibco, Rockville, MD, USA) but
containing 10% fetal bovine serum (FBS; Invitrogen-Gibco) and
100 U/ml penicillin/streptomycin (Invitrogen-Gibco) in a humid-
iﬁed 5% CO2 atmosphere at 37 ◦C. The media was  replaced
at three day intervals. Neuroblastoma cells were subcultured
when they reached 80–90% conﬂuence. The numbers of neurob-
lastoma cells were counted using the manual hemocytometer
method.
2.2. Repetitive magnetic stimulation
Dishes of cultured cells were randomly allocated into the follow-
ing three groups: untreated controls (n = 4), low-frequency (0.5 Hz)
stimulation group (n = 4), and high-frequency (10 Hz) stimulation
group (n = 4). Brieﬂy, the coil was placed above a single dish (one
dish per treatment group), and its center was aligned with the
center of the dish; the distance between the dimensional center
of the coil and the culture dish was 1.0 cm.  The repetitive mag-
netic stimulation was performed with 0.5 Hz and 10 Hz frequencies
(on-off interval, 3 s), with a 100% machine output stimulation
intensity at a stimulation duration of 20 min  per day. The treat-
ments were performed daily for 3 days. Control neurons were
handled in a similar manner to the treatment group exposed to
the magnetic stimulation apparatus for the identical length of
time but was shielded by Mu  metal, therefore did not receive any
stimulation.
2.3. Western blotting
To compare the expression levels of neurotrophic factors, neu-
roblastoma cells (n = 4 per group) were lysed in 300 l of cold
RIPA buffer (50 mM Tris–HCl, pH 7.5, 1% Triton X-100, 150 mM
NaCl, 0.1% sodium dodecyl sulfate (SDS), and 1% sodium deoxy-
cholate) with a protease inhibitor cocktail (Sigma–Aldrich, St. Louis,
MO,  USA). Cells lysate was  centrifuged at 13,000 × g for 15 min at
4 ◦C. The supernatant was harvested, and protein concentration
was analyzed using a Qunt-iT protein assay kit (Molecular Probes,
Eugene, Oregon, USA). For electrophoresis, 50 g of protein was
dissolved in a sample buffer (60 mM Tris–HCl, pH 6.8, 14.4 mM
-mercaptoethanol, 25% glycerol, 2% SDS, and 0.1% bromophenol
blue), boiled for 10 min  and separated on a 10% SDS reducing gel.
Separated proteins were transferred onto polyvinylidene diﬂuoride
(PVDF) membranes (Invitrogen, Carlsbad, CA) using a trans-blot
system. Blots were blocked for 1 h in Tris-buffered saline (TBS)
(10 mM Tris–HCl, pH 7.5, 150 mM NaCl) containing 5% nonfat dry
milk at room temperature, washed three times with TBS and incu-
bated at 4 ◦C overnight with an anti-rabbit polyclonal brain-derived
neurotrophic factor (BDNF, 1:1000, Abcam, Cambridge, MA,  USA),
anti-rabbit glial cell-derived neurotrophic factor (GDNF, 1:1000,
Abcam), anti-rabbit neurotrophin-3 (NT-3, 1:1000; Abcam), anti-
rabbit platelet-derived growth factor (PDGF, 1:1000; Abcam), and
anti- actin (1:3000, Cell signaling, Boston, MA,  USA) antibody in
TBST (10 mM Tris, pH 7.5, 150 mM NaCl, and 0.02% Tween 20) con-
taining 5% nonfat dry milk. On the next day, blots were washed
three times with TBST and incubated for 1 h at room tempera-
ture with horseradish peroxidase-conjugated secondary antibodies
(1:3000, Santa Cruz Biotech, Santa Cruz, CA, USA) in TBST con-
taining 3% nonfat dry milk. After washing three times with TBST,
proteins were visualized with an ECL detection system (Amersham
Pharmacia Biotech, Piscataway, NJ, USA).
2.4. Blockage of growth factors
To determine the relation between growth factors and cell pro-
liferation, we  used NT-3, GDNF and PDGF blocking peptide. Mouse
neuroblastoma cells were seeded at a density of 1 × 106 cells/cm2
in 100 culture dish. After 24 h, cells were washed with Dulbecco’s
phosphate buffered saline (DPBS; Invitrogen-Gibco) ﬁve times, and
media were replaced with serum-free media containing 2 g/ml
NT-3 blocking peptide (Santa Cruz Biotech), GDNF blocking pep-
tide (Biovision, CA, USA) and PDGF blocking peptide (Santa Cruz
Biotech). Cells were incubated with or without growth factor block-
ing peptides for 12 h. The cells were then treated rTMS stimulation
with 0.5 Hz and 10 Hz daily for 3 days.
2.5. Statistical analysis
Results shown in the bar graphs are the mean ± SE of at least 4
independent experiments. Statistical analysis of cell proliferation
was performed in untreated, 0.5 Hz and 10 Hz stimulation groups
using t-test and analysis of variance (ANOVA) with post hoc Bon-
ferroni comparison. A P-value <0.05 was  considered statistically
signiﬁcant.
3. Results
3.1. Immunoblot analysis of neuronal growth factors
To identify the growth factors associated with the functional
recovery repair process and the neuroprotective and/or neu-
rorestorative effects induced by repetitive magnetic stimulation,
the expressions of various neurotrophic/growth factors including
BDNF, GDNF, NT-3, and PDGF were investigated using Western blot
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Fig. 1. Expression of neurotrophic/growth factors increase after repetitive magnetic stimulation in neuroblastoma cells. (A) Representative expressions of BDNF, GDNF, NT-3,
and  PDGF in neuroblastoma cells (NIE-115) after high-frequency (10 Hz) and low-frequency (0.5 Hz) stimulation. (B–E) The relative amounts of neurotrophic/growth factors
(n  = 4 each group). The expression levels of BDNF (B), GDNF (C), NT-3 (D), and PDGF (E) signiﬁcantly increased in the high-frequency stimulation group. Control: untreated; LF-
rMS:  low-frequency repetitive magnetic stimulation; HF-rMS: high-frequency repetitive magnetic stimulation. The values are expressed as mean±SE. **p < 0.01, ***p  < 0.001
comparison with control group (non-treatment). ##p < 0.01, ###p < 0.001 comparison with low-frequency stimulation group.
analysis (Fig. 1). The level of BDNF was signiﬁcantly elevated in
the high-frequency stimulation group (10 Hz) compared with the
low-frequency stimulation group (0.5 Hz) and the non-treatment
group (Fig. 1B) (p < 0.01, F = 14.19). The level of GDNF was signif-
icantly elevated in the high-frequency stimulation group (10 Hz)
compared with the low-frequency stimulation group (0.5 Hz) and
the non-treatment group (Fig. 1C) (p < 0.01, F = 15.07). The level of
NT-3 was signiﬁcantly elevated in the high-frequency stimulation
group (10 Hz) compared with the low-frequency stimulation group
(0.5 Hz) and the non-treatment group (Fig. 1D) (p < 0.01, F = 12.64).
The level of PDGF was signiﬁcantly elevated in the high-frequency
stimulation group (10 Hz) compared with the low-frequency stim-
ulation group (0.5 Hz) and the untreated group (Fig. 1E) (p < 0.001,
F = 114.1).
3.2. High frequency stimulation increased ERK and Akt expression
Our study showed that repetitive magnetic stimulation changed
the expression of signaling cascades including ERK and Akt related
to the neurotrophic/growth factors, which are associated with cell
survival and proliferation. Akt and ERK were investigated using
the Western blot analysis (Fig. 2). The Akt protein expression was
signiﬁcantly increased in the high-frequency stimulation group
compared with the control and low-frequency group (p < 0.001,
F = 85.19). But the level of Akt protein signiﬁcantly decreased in
the low-frequency group compared to the control group (p < 0.001)
(Fig. 2B). The level of ERK protein was signiﬁcantly increased in
the high-frequency stimulation group compared with the con-
trol and low-frequency stimulation group (p < 0.001, F = 12.64),
while low-frequency stimulation signiﬁcantly decreased the level
of ERK protein compared with only high-frequency stimulation
(p < 0.0001).
3.3. Neuroblastoma cell proliferation after repetitive magnetic
stimulation
Repetitive magnetic stimulation (circular coil, 100% of motor
threshold, 20 min/day) was  used to treat mouse neuroblastoma
cells for 4 days. Following the untreated and 0.5 Hz stimula-
tion treatment, the number of neuroblastoma cells signiﬁcantly
decreased at 4 days. In contrast, the number of neuroblas-
toma cells signiﬁcantly increased in the 10 Hz stimulation group
(Fig. 3A). Compared to the corresponding untreated and the low-
frequency stimulation treated neuroblastoma cells, proliferation
rates of 10 Hz treated cells were 487% at 4 days. The num-
ber of cells of the high-frequency group was signiﬁcantly higher
(4.05 × 105 ± 25000) than the control group (8.3 × 104 ± 3000).
However, the number of cells were not signiﬁcantly differ-
ent between the low-frequency group (6.75 × 104 ± 12500) and
the untreated group (8.3 × 104 ± 3000) at 4 days post-treatment
(Table 1 and Fig. 2) (p < 0.01). The proliferation effect of repetitive
magnetic stimulation was  conﬁrmed only in the high-frequency
stimulation group (Fig. 3B).
4. Discussion
rTMS is now well-established that high-frequency stimulation
increases human cortical excitability for minutes to even hours
beyond the stimulation period [14]. Depending on the stimu-
lation frequency, rTMS is able to temporarily modulate cortical
excitability and produce consistent, long-lasting effects on phys-
iology within the cortex [15]. However, the previous study did
not clarify the effect on regulation of various growth factors
and cellular and molecular changes by its different frequencies
in vitro. Therefore, the purpose of this study was to provide
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Fig. 2. Expression of Akt and Erk protein after repetitive magnetic stimulation in neuroblastoma cells. (A) Representative expressions of Akt and Erk protein in neuroblastoma
cells  (NIE-115) after high-frequency (10 Hz) and low-frequency (0.5 Hz) stimulation. (B and C) The relative amounts of Akt and Erk protein (n = 4 each group). The expression
levels  of Akt (B) and Erk (C) signiﬁcantly increased after high-frequency stimulation. Control: untreatedl; LF-rMS: low-frequency repetitive magnetic stimulation; HF-rMS:
high-frequency repetitive magnetic stimulation. The values are expressed as mean±SE. **p < 0.01, ***p < 0.001 comparison with control group (non-treatment). ##p < 0.01,
###p  < 0.001 comparison with low-frequency stimulation group.
Fig. 3. Effect on the proliferation of neuroblastoma cells treated with repetitive magnetic stimulation. (A) The high-frequency stimulated cells were signiﬁcantly increased
than  control (untreated) and low-frequency treated cells. (B) The number of neuroblastoma cells signiﬁcantly increased in high-frequency stimulation group compared with
control  and low-frequency groups. Control: untreated; LF-rMS: low-frequency repetitive magnetic stimulation; HF-rMS: high-frequency repetitive magnetic stimulation.
The  values are expressed as mean ± SE. **p < 0.01, ***p < 0.001 comparison with control group (non-treatment). ##p < 0.01, ###p < 0.001 comparison with low-frequency
stimulation group.
Table 1
The number of neuroblastoma cells after repetitive magnetic stimulation.
Control (untreated) Low-frequency (0.5 Hz) High-frequency (10 Hz)
Mouse neuroblastoma cells 8.3 × 104 ± 3000 6.75 × 104 ± 12500 4.05 × 105 ± 25000
Values are mean ± SEM.
experimental evidence that in vitro repetitive magnetic stimula-
tion induces neuroblastoma cell proliferation and growth factors
following low-frequency (0.5 Hz) and high-frequency (10 Hz) stim-
ulation. This study examined the changes in expression of BDNF,
GDNF, NT-3 and PDGF, and cell proliferation in immortalized mouse
neuroblastoma cells.
Neurotrophic/growth factor results showed that high-
frequency stimulation increased expression of BDNF. This
result is in concordance with recent literature that assumes
high-frequency magnetic stimulation induces the BDNF signaling
pathway [10,11,16]. While low-frequency stimulation decreased
expression of BDNF in neuroblastoma cells, this result conﬂicted
with previous studies in rats and humans. However, due to insuf-
ﬁcient results further studies are required to conﬁrm our ﬁndings.
Our results also demonstrated that high-frequency stimulation
increased the levels of GDNF, NT3 and PDGF in neuronal cells,
while low-frequency stimulation did not facilitate or decrease
expression of GDNF, NT-3, and PDGF in target cells. These results
may  be the ﬁrst to demonstrate that different frequencies of
repetitive magnetic stimulation regulate GNDF, NT-3 and PDGF in
neuroblastoma cells. In addition, this study examined the changes
in expression of signaling cascades related to cell proliferation,
such as the Akt and Erk protein as well as neurotrophic and growth
factors. Akt and Erk are well known signaling cascades which
J.Y. Lee et al. / Neuroscience Letters 604 (2015) 167–172 171
transmits survival signals from growth factors to regulate cell
survival and proliferation [17,18].
In this study, we investigated the effects of different frequencies
of repetitive magnetic stimulation on cell proliferation. We  demon-
strated that high-frequency stimulation signiﬁcantly increased
proliferation in neuroblastoma cells, while low-frequency stimula-
tion decreased cell proliferation. This study showed that repetitive
magnetic stimulation activated or inactivated signaling pathways
associated with cell proliferation and growth factor expression. It
seems that repetitive magnetic stimulation modulates intracellu-
lar signaling or gene expression, as well as synaptic activity and/or
mediating inter-hemispheric balance of neural activity. Particu-
larly, high-frequency stimulation increased four growth factors
such as BDNF, GDNF, NT3, and PDGF and activated the Akt and Erk
signaling cascades in neuroblastoma cells.
Neurotrophins/growth factors such as BDNF and NT-3 regulate
synaptic strength and thereby mediate plasticity. Moreover, ample
evidence supports an important role of BDNF, GDNF, NT3, and PDGF
in the survival, development, differentiation, and regeneration of
neurons [19,20,21,22], as well as in synaptic transmission and
plasticity [23,24]. In a previous study [11], high-frequency stimu-
lation signiﬁcantly increased expression of various growth factors
(BDNF, GDNF, NGF, PDGF, and VEGF) associated with the repair
process of functional recovery and the neuroprotective and/or
neurorestorative effects in an animal model with Parkinson’s dis-
ease. Considering our results, high-frequency stimulation increased
expression of various growth factors and Akt and Erk related to
proliferation and survival, causing increased proliferation in neu-
roblastoma cells.
In this study, we proposed the repetitive magnetic stimulation
effects on cell proliferation are mediated by growth factors. When
we treated anti-growth factor blockers on neuroblast cells, and
then treated with repetitive magnetic stimulation with different
frequencies, the number of cells decreased in the NT-3-, GDNF-,
and PDGF-blocked cell groups, suggesting that blockage of growth
factors reduced cell proliferation induced by repetitive magnetic
stimulation (Fig. S1). There is evidence about the effect of growth
factors with their downstream signaling cascade such as Akt and
Erk on cell proliferation [21]. Our results also demonstrated that the
effect of cell proliferation following repetitive magnetic stimulation
might be mediated via action of growth factors.
As a limitation to this study, the mechanism of repetitive
magnetic stimulation using variable frequencies was not eluci-
dated in the cellular/molecular study. This is the ﬁrst in vitro
study of the expression of various growth factors and cell prolif-
eration following repetitive magnetic stimulation with different
frequencies. Many reports demonstrated that high frequency
stimulation excited synaptic activation, and low frequency stim-
ulation inhibited synaptic activation in human studies [3,4,5,6].
Previous studies also suggested that high or low frequency stim-
ulation activated signaling pathways, such as the BDNF-TrkB,
MAPK/ErK, and PI3K/Akt pathways to upregulate expression of
the downstream effector molecules and synaptic protein and
neurogenesis [1,10,13,16,17]. As the mechanism of repetitive mag-
netic stimulation using different frequencies is still uncertain,
further studies are needed to elucidate cellular and molecular
mechanisms.
Another limitation of this study is that we did not use the neuro-
sphere from SVZ. In this study, we used the mouse neuroblastoma
cells (NIE115) that have been shown to be a suitable cell line for the
research of neuronal differentiation, neurotransmitter release, and
cellular and molecular mechanisms of neuron properties. To deter-
mine the expression of growth factors and signaling cascades by
repetitive magnetic stimulation, we used the NIE115 cells. How-
ever, a study using the neurosphere from SVZ can provide more
clinically important results. Therefore, further study is needed to
elucidate the effects of repetitive magnetic stimulations using the
neurosphere from SVZ.
In summary, our study provides evidence that different fre-
quencies of repetitive magnetic stimulation differentially modulate
neuroblastoma cell proliferation and growth factor expression.
Although the result of this study may  provide a novel and also valu-
able theoretical background for clinical applications of repetitive
magnetic stimulation, further investigation is needed to elucidate
the exact underlying mechanism.
5. Conclusion
Our results provide evidence that different frequencies of repet-
itive magnetic stimulation modulate growth factor expression and
neuroblastoma cell proliferation in different ways. To our knowl-
edge, these ﬁndings may  be the ﬁrst to demonstrate differential
effects of repetitive magnetic stimulation on the expression of Akt
and Erk, as well as various growth factors such as BDNF, GDNF,
NT3, and PDGF, and even neuronal cell proliferation. These results
of repetitive magnetic stimulation may  provide a foundation for
additional clinical studies.
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